Clinical Assessment of COPD

作者: Jørgen Vestbo

DOI: 10.1007/978-1-59745-357-8_2

关键词: Respiratory systemFunctional impairmentInternal medicineSputum ProductionCOPDMedicinePulmonary diseaseMedical diagnosisSpirometryValue (mathematics)

摘要: Chronic obstructive pulmonary disease (COPD) should be suspected in any patient aged 40 years or more with symptoms of cough, sputum production, breathlessness and/or a history exposure to risk factors, particular smoking. When seeing patients respiratory smokers – think COPD Do spirometry Exclude differential diagnoses, perform chest x-ray Assess functional impairment, by interview and even better testing When possible, standardize your questioning Consider further physiological testing imaging Calculate BMI, it has prognostic value

参考文章(25)
Neil J. Douglas, Peter M. A. Calverley, David C. Flenley, Vlasta Brezinova, James R. Catterall, The effect of oxygenation on sleep quality in chronic bronchitis and emphysema The American review of respiratory disease. ,vol. 126, pp. 206- 210 ,(1982) , 10.1164/ARRD.1982.126.2.206
Nestor L. Müller, Catherine A. Staples, Roberta R. Miller, Raja T. Abboud, “Density Mask”: An Objective Method to Quantitate Emphysema Using Computed Tomography Chest. ,vol. 94, pp. 782- 787 ,(1988) , 10.1378/CHEST.94.4.782
J.M. Antó, P. Vermeire, J. Vestbo, J. Sunyer, Epidemiology of chronic obstructive pulmonary disease European Respiratory Journal. ,vol. 17, pp. 982- 994 ,(2001) , 10.1183/09031936.01.17509820
D E O'Donnell, J C Bertley, L K Chau, K A Webb, Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. American Journal of Respiratory and Critical Care Medicine. ,vol. 155, pp. 109- 115 ,(1997) , 10.1164/AJRCCM.155.1.9001298
J.A. Smith, P.M.A. Calverley, Cough in chronic obstructive pulmonary disease Pulmonary Pharmacology & Therapeutics. ,vol. 17, pp. 393- 398 ,(2004) , 10.1016/J.PUPT.2004.09.006
ROMAIN A. PAUWELS, A. SONIA BUIST, PETER M. A. CALVERLEY, CHRISTINE R. JENKINS, SUZANNE S. HURD, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine. ,vol. 163, pp. 1256- 1276 ,(2001) , 10.1164/AJRCCM.163.5.2101039
E. B Swallow, D. Reyes, N. S Hopkinson, W. D-C Man, R. Porcher, E. J Cetti, A. J Moore, J. Moxham, M. I Polkey, Quadriceps strength predicts mortality in patients with moderate to severe Chronic Obstructive Pulmonary Disease Thorax. ,vol. 62, pp. 115- 120 ,(2007) , 10.1136/THX.2006.062026
J Vestbo, E Prescott, P Lange, Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. American Journal of Respiratory and Critical Care Medicine. ,vol. 153, pp. 1530- 1535 ,(1996) , 10.1164/AJRCCM.153.5.8630597
Jørgen Vestbo, Peter Lange, Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine. ,vol. 166, pp. 329- 332 ,(2002) , 10.1164/RCCM.2112048